Clinical Trials Details

Lung Cancer

A RANDOMIZED PHASE III COMPARISON OF STANDARD- DOSE (60 Gy) VERSUS HIGHDOSE (74 Gy) CONFORMAL RADIOTHERAPY WITH CONCURRENT AND CONSOLIDATION CARBOPLATIN/PACLITAXEL +/- CETUXIMAB (IND# 103444)IN PATIENTS WITH STAGE IIIA/IIIB NON-SMALL CELL LUNG CANCER

Trial ID: 07178

Contact: Denise L Elmore

Phone: (281)863-4609

Learn More about this trial.

go back | new search

This Study is currently being offered at the following Sites:

Practice	State/City
New York Oncology Hematology, P.C.	Albany, NY (Patroon)
Rocky Mountain Cancer Centers, LLP	Aurora, CO
Texas Oncology, P.A.	Bedford, TX (Edwards CC)(RAD)
Texas Oncology, P.A.	Fort Worth, TX (12th Ave.)
Texas Oncology, P.A.	Fort Worth, TX (8th) Rad Only
Texas Oncology, P.A.	Fort Worth, TX (Klabzuba) Rad
Central Indiana Cancer Centers	Indianapolis, IN (E. County)
Kansas City Cancer Center, LLC.	Kansas City, MO (North)
Texas Oncology, P.A.	Longview, TX
Texas Oncology, P.A.	Odessa, TX
Kansas City Cancer Center, LLC.	Overland Park, KS (CBO)
Texas Oncology, P.A.	Sherman, TX
Texas Oncology, P.A.	Sugar Land, TX
Arizona Oncology Associates, PC - SRO	Tucson, AZ (Orange Grove Rd)
Arizona Oncology Associates, PC - HOPE	Tucson, AZ (Rudasill - HOPE)